Can a new patient cohort unlock the secrets of TB treatment success?
NCT ID NCT04236349
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This pilot study aims to test the feasibility of creating a large-scale cohort of tuberculosis (TB) patients in northern Paris, an area with high TB rates. Researchers will collect blood samples and clinical data from 30 participants over the course of their treatment to understand patient characteristics and treatment outcomes. The goal is to identify factors that may lead to adverse outcomes and ultimately improve TB control in the region.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- blood sample collection for immunogenetic analysis
- What this could lead to
- If successful, this pilot could pave the way for a large-scale TB cohort in France, helping identify factors linked to poor treatment outcomes and informing better TB control strategies.
- What could go wrong
- This is a small pilot study focused on feasibility, not treatment efficacy. It may not capture all relevant patient characteristics, and findings may not generalize beyond the specific population in northern Paris.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRA PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Avicenne
Bobigny, Seine Saint Denis, 93000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shorter TB treatment: a 4-Month regimen put to the test
- Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
- Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Talking it out: could counseling be the key to beating TB?
- New TB vaccine aims to prevent active lung disease in adults